Ally Financial’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-20,000
Closed -$3.54M 131
2020
Q1
$3.54M Hold
20,000
0.38% 53
2019
Q4
$3.82M Hold
20,000
0.63% 50
2019
Q3
$3.37M Hold
20,000
0.6% 56
2019
Q2
$3.35M Hold
20,000
0.58% 55
2019
Q1
$2.93M Hold
20,000
0.56% 60
2018
Q4
$2.67M Hold
20,000
0.35% 63
2018
Q3
$3.81M Hold
20,000
0.76% 42
2018
Q2
$3.33M Buy
20,000
+4,000
+25% +$642K 0.66% 48
2018
Q1
$2.69M Hold
16,000
0.4% 68
2017
Q4
$2.62M Hold
16,000
0.51% 59
2017
Q3
$3.28M Hold
16,000
0.62% 51
2017
Q2
$3.89M Hold
16,000
0.77% 46
2017
Q1
$3.82M Buy
16,000
+1,000
+7% +$233K 0.86% 37
2016
Q4
$3.15M Hold
15,000
0.53% 51
2016
Q3
$3.46M Hold
15,000
0.61% 43
2016
Q2
$3.47M Hold
15,000
0.58% 57
2016
Q1
$4.02M Hold
15,000
0.56% 54
2015
Q4
$4.69M Buy
15,000
+5,000
+50% +$1.49M 0.65% 46
2015
Q3
$2.72M Buy
10,000
+2,000
+25% +$614K 0.28% 80
2015
Q2
$2.43M Buy
8,000
+3,000
+60% +$895K 0.25% 97
2015
Q1
$1.49M Buy
+5,000
New +$1.43M 0.15% 122

Other funds holding AGN

Ally Financial's AGN Position: Q2 2020 in Review

Ally Financial sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 20,000 shares — an estimated $3.54M sold.

Ally Financial first reported a position in AGN in Q1 2015 and held it in 21 quarters. The position peaked at $4.69M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Ally Financial reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Ally Financial sold 20,000 Allergan plc shares in Q2 2020, an estimated $3.54M.
  • Ally Financial first reported a position in Allergan plc in Q1 2015 and held it in 21 quarters.
  • Ally Financial's Allergan plc position peaked at $4.69M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Ally Financial's 13F filing for Q2 2020, filed 13 Aug 2020.